Effects of Camellia tea and herbal tea on cardiometabolic risk in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis of randomized controlled trials

Peng Wang,Kang Geng,Zong Zhe Jiang,Pei Yu Yan,Yong Xu,Xiu Mei Ma
DOI: https://doi.org/10.1002/ptr.7572
IF: 6.388
2022-10-07
Phytotherapy Research
Abstract:Evidence for the anti‐diabetic actions of camellia and herbal tea in diabetic patients has not been summarized. Several data sources were searched for randomized trials assessing the effect of different teas on cardiometabolic risk factors in T2D subjects. Two independent reviewers extracted relevant data and assessed the risk of bias. Results were summarized using mean differences (MDs) based on a random model. Sixteen studies (19 trials, N = 832) fulfilled the eligibility criteria. Mean differences were measured for body weight, body mass index, fasting blood glucose, glycosylated hemoglobin, a homeostatic model for insulin resistance, high and low‐density lipoproteins, triglycerides, and systolic and diastolic blood pressure. No effects on total cholesterol and waist circumference were observed when either camellia or herbal tea was consumed. Tea produced moderate regulatory effects on adipose, glycemic control, lipid profiles, and blood pressure. In terms of efficacy, camellia and herbal teas yield different benefits in regulating metabolism. This discovery has some implications for clinical research and drug development. However, more high‐quality trials are needed to improve the certainty of our estimates.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?